Including R&D, Management , Marketing Center and Diagnostic production.

Immunological Diagnostic Reagents (Class A) GMP Production Line (Capacity: 10,000 Kits);
Molecular Biology Diagnostic Reagents (Class B) GMP Production Line (Capacity: 10,000 Kits);
mRNA Vaccine & Drug Production Line (Under Construction) (Designed Capacity: 100 Million Doses).

Established in 2014,Phase I and Phase II projects have been completed with an investment of 143 million RMB, Phase III project is under construction.
With the production pipelines :
1.Cell Suspension Culture FMD Inactivated Vaccine Production Line ( Capacity: 250 Million Doses);
2.Synthetic Peptide Production Line (Capacity: 400 Million Doses);
3.Cell Suspension Culture Viral Subunit Vaccine Production Line (Capacity: 350 Million Doses);
4.Cell Suspension Culture Viral Inactivated Vaccine Production Line (Capacity: 175 Million Doses);
5.Cell Suspension Culture Subunit Vaccine Production Line ( Capacity: 400 Million Doses);
6.Bacterial Inactivated Vaccine Production Line (Capacity: 60 Million Doses);
7.Live Vaccine Production Line (Under Construction) (Designed Capacity: 200 Million Doses).